Lead Product(s) : AMY109
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : AMY109 is a novel therapeutic antibody with a recycling function that binds to IL-8 (an inflammatory cytokine) and improves inflammation and fibrosis in endometriosis.
Product Name : AMY109
Product Type : Antibody
Upfront Cash : Inapplicable
February 24, 2023
Lead Product(s) : AMY109
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Preclinical
Sponsor : Fast Track Initiative
Deal Size : $30.3 million
Deal Type : Series B Financing
LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing
Details : Proceeds from financing will also be used to establish a robust manufacturing system based on its proprietary Mitochondrial Isolation Technology platform, a novel method for intact, shelf-stable and highly functional isolated mitochondria as a biopharmac...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 06, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Preclinical
Sponsor : Fast Track Initiative
Deal Size : $30.3 million
Deal Type : Series B Financing
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Preclinical
Sponsor : University of Oxford
Deal Size : Undisclosed
Deal Type : Collaboration
Details : This collaboration was formed in order to realise this solution and seeks to address this by specifically delivering therapeutics to the placenta, combining unique technology developed at LUCA Science with extensive placental research experience at the U...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 09, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Preclinical
Sponsor : University of Oxford
Deal Size : Undisclosed
Deal Type : Collaboration